MUMBAI, Oct 10 (Reuters) - Indian drug maker Lupin Ltd (LUPN.BO) said on Wednesday it had acquired a majority stake in Japanese generic drug maker Kyowa Pharmaceutical Industry Co Ltd. It did not give financial details but CNBC-TV 18, citing unidentified sources, said Lupin paid $60 million for the acquisition. Lupin’s shares were up 2.7 percent at 601 rupees at 0716 GMT in a firm Mumbai market.
((Reporting by Himangshu Watts, editing by Ranjit Gangadharan; Reuters Messaging: email@example.com +91 22 6636 9030)) Keywords: LUPIN ACQUISITION/
C Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nBMA001661